A California plaintiff, who used Roundup on his 56-acre Santa Rosa property and alleged glyphosate caused his non-Hodgkin lymphoma, has been awarded $80 million by a jury in the U.S. District Court for the Northern District of California. The docket of the case, Hardeman v. Monsanto Co. et al., is available here (subscription required). This verdict is the second significant glyphosate judgment against Bayer-owned Monsanto, following on the August 2018 verdict that awarded a former school groundskeeper $289 million (later reduced to $78 million by a judge reviewing the case).
In a statement after the verdict, Bayer expressed disappointment but stressed that the science supports that its glyphosate products are not carcinogenic. In particular, Bayer quoted a recent Health Canada statement that “no pesticide regulatory authority in the world currently considers glyphosate to be a cancer risk to humans at the levels at which humans are currently exposed.”
Hundreds of additional cases are forthcoming, including a federal multi-district litigation scheduled to begin at the U.S. District Court for the Northern District of California on May 20, 2019.